Compare Stocks → Millionaire Investor makes surprising election prediction (From InvestorPlace) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BTCYNASDAQ:MBOTNASDAQ:NXGLNASDAQ:PETV Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTCYBiotricity$1.06+1.0%$1.30$0.70▼$4.37$9.99M1.5484,017 shs16,775 shsMBOTMicrobot Medical$0.94-3.1%$1.05$0.86▼$4.37$13.54M1.777,131 shs49,184 shsNXGLNEXGEL$2.37+3.5%$2.36$1.46▼$3.14$14.73M0.811,355 shs34,242 shsPETVPetVivo$0.78+8.3%$0.86$0.33▼$2.90$13.14M2.1523,356 shs24,147 shs7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTCYBiotricity+0.58%-13.47%-16.54%+9.28%+105,999,900.00%MBOTMicrobot Medical-2.83%+1.82%+4.46%-27.12%-21.00%NXGLNEXGEL+3.28%+7.50%+5.58%+10.51%+41.19%PETVPetVivo+8.82%+11.93%+8.82%-36.96%-63.39%get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTCYBiotricityN/AN/AN/AN/AN/AN/AN/AN/AMBOTMicrobot Medical1.6332 of 5 stars3.53.00.00.02.50.80.0NXGLNEXGEL0.6982 of 5 stars0.04.00.00.01.93.30.0PETVPetVivoN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTCYBiotricity2.00HoldN/AN/AMBOTMicrobot Medical3.00Buy$7.00644.60% UpsideNXGLNEXGELN/AN/AN/AN/APETVPetVivoN/AN/AN/AN/ACurrent Analyst RatingsLatest NXGL, MBOT, BTCY, and PETV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/16/2024MBOTMicrobot MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.00 ➝ $7.00(Data available from 5/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTCYBiotricity$9.64M1.04N/AN/A($2.27) per share-0.47MBOTMicrobot MedicalN/AN/AN/AN/A$0.43 per shareN/ANXGLNEXGEL$4.09M3.60N/AN/A$0.84 per share2.82PETVPetVivo$920K14.28N/AN/A$0.07 per share11.19Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTCYBiotricity-$18.66M-$1.39N/AN/AN/A-125.43%N/A-233.67%7/4/2024 (Estimated)MBOTMicrobot Medical-$10.74M-$0.89N/A∞N/AN/A-149.24%-115.69%8/12/2024 (Estimated)NXGLNEXGEL-$3.16M-$0.55N/A∞N/A-67.48%-54.71%-31.35%8/12/2024 (Estimated)PETVPetVivo-$8.72M-$0.86N/A∞N/A-1,016.64%-1,319.59%-299.92%7/4/2024 (Estimated)Latest NXGL, MBOT, BTCY, and PETV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2024Q1 2024MBOTMicrobot Medical-$0.17-$0.17N/A-$0.17N/AN/A4/1/2024Q4 2023NXGLNEXGELN/A-$0.19-$0.19-$0.19N/A$1.08 million3/27/2024Q4 2023MBOTMicrobot Medical-$0.25-$0.26-$0.01-$0.26N/AN/A2/20/2024Q3 2024BTCYBiotricity-$0.41-$0.34+$0.07-$0.34$3.00 million$2.97 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTCYBiotricityN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/AN/ANXGLNEXGELN/AN/AN/AN/AN/APETVPetVivoN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTCYBiotricityN/A0.210.10MBOTMicrobot MedicalN/A5.922.09NXGLNEXGEL0.201.961.46PETVPetVivo0.020.900.62OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTCYBiotricity3.89%MBOTMicrobot Medical16.30%NXGLNEXGEL2.21%PETVPetVivo24.55%Insider OwnershipCompanyInsider OwnershipBTCYBiotricity20.46%MBOTMicrobot Medical10.64%NXGLNEXGEL27.15%PETVPetVivo20.10%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBTCYBiotricity559.42 million7.49 millionOptionableMBOTMicrobot Medical2114.40 million12.87 millionOptionableNXGLNEXGEL196.23 million4.54 millionNot OptionablePETVPetVivo2516.77 million13.40 millionNot OptionableNXGL, MBOT, BTCY, and PETV HeadlinesRecent News About These CompaniesMay 9, 2024 | americanbankingnews.comPetVivo (NASDAQ:PETV) Trading Up 3.4%April 24, 2024 | investing.comPetvivo enacts cost cuts, executives take salary reductionsApril 19, 2024 | investing.comPetVivo Holdings CEO acquires $90k in company stockApril 18, 2024 | insidertrades.comPetVivo Holdings, Inc. (NASDAQ:PETV) CEO Buys $90,000.00 in StockApril 8, 2024 | globenewswire.comPETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANAApril 3, 2024 | globenewswire.comPETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDAMarch 15, 2024 | fortune.comAT&T’s CFO on how the company saved $6 billion—and is planning to scrimp another $2 billion by 2026March 14, 2024 | globenewswire.comSmallCapVoice.com Inc. (“SCV”) to Host First Annual Safety Summit featuring Up-and-Coming Public CompaniesMarch 11, 2024 | msn.comPetVivo terminates ATM sales agreement with ThinkEquityMarch 11, 2024 | markets.businessinsider.comPetVivo Holdings Names Garry Lowenthal CFOMarch 11, 2024 | globenewswire.comGarry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial OfficerMarch 8, 2024 | finance.yahoo.comNew to The Street Announces its Five Corporate TV Interviews, Airing Episode 561 on the FOX Business Network Monday, March 11, 2024, at 10:30 PM PTMarch 5, 2024 | finance.yahoo.comPetVivo Holdings, Inc. Commences Trading on Upstream Under PETVFebruary 29, 2024 | globenewswire.comClinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, CaliforniaFebruary 27, 2024 | finance.yahoo.comPetVivo Holdings, Inc. Approved to Dual List on UpstreamFebruary 15, 2024 | investing.comPetVivo reports revenue growth and net loss reduction in Q3February 14, 2024 | cbonds.comPetVivo Holdings: Results Of Operations And Financial Condition, Financial Statements And ExhibitsFebruary 14, 2024 | finance.yahoo.comPetVivo Holdings Third Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.23 loss in 3Q 2023)February 13, 2024 | finance.yahoo.comPetVivo Holdings, Inc. (NASDAQ:PETV) Q3 2024 Earnings Call TranscriptFebruary 13, 2024 | finanznachrichten.dePetVivo Holdings, Inc.: PetVivo Reports Third Quarter of Fiscal 2024 Financial ResultsNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackHow to Use Put Debit Spreads to Profit From Falling Stocks April 26, 2024 9:30 AMView How to Use Put Debit Spreads to Profit From Falling Stocks Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsSeagate Technology Warns Cloud Demand is Heating Up April 30, 2024 10:10 AMView Seagate Technology Warns Cloud Demand is Heating Up New Highs in Sight For Symbotic and its AI Warehouse AutomationMay 10, 2024 7:03 AMView New Highs in Sight For Symbotic and its AI Warehouse AutomationAll HeadlinesCompany DescriptionsBiotricityNASDAQ:BTCYBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Microbot MedicalNASDAQ:MBOTMicrobot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. In addition, it provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.NEXGELNASDAQ:NXGLNEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.PetVivoNASDAQ:PETVPetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.